blog

Agree or Disagree: Smaller Pharma Companies Are Leading the Way in Digital Health

By BBK Worldwide on Tue, Jul 24, 2018 | 1 min read

For digital health to be more widely implemented across the healthcare industry, smaller biopharma companies must be the first to demonstrate its efficacy. In this way, they must deliver specific real-world cases to prove to bigger pharma companies that digital health solutions are viable for the clinical R&D industry.

Topics: digital health, mHealth, clinical research, clinical trials

Experts Debate: Is the Future Now for Mobile Technology and the Patient Experience?

By BBK Worldwide on Thu, Jul 12, 2018 | 1 min read

With regard to the adoption and use of digital health solutions in clinical R&D, where are we as an industry? In our latest Pharma15 Live! debate, BBK Worldwide founding principal Bonnie A. Brescia posed this question to the panel of industry experts. Justin Johnson, CEO of Biotaware, answered in no uncertain terms: “[the industry] is five to eight years behind where it should be.” Do you agree?

Topics: Pharma15, Most Viewed

Taming the Study Data Explosion at DIA 2018

By BBK Worldwide on Wed, Jun 27, 2018 | 2 min read

While it’s hard to believe that today is the last day on the DIA 2018 exhibition floor, we are excited to continue collaborating, presenting, and interacting with our industry colleagues. Our poster session “Real World Data Meets Real World Evidence in Patient Recruitment and Engagement” made way for productive conversation that embodies the spirit of the DIA Annual Meeting. Today, we are back with a new poster session titled “Taming the Study Data Explosion: How to Leverage KPIs to Maximize Performance.”

Topics: DIA 2018, KPIs, clinical research, clinical trials

Real World Data Meets Real World Evidence at BBK's DIA 2018 Poster Session

By BBK Worldwide on Tue, Jun 26, 2018 | 2 min read

With the first day on the DIA 2018 exhibition floor behind us, we are really looking forward to the next couple days of learning and collaborating with our industry colleagues. Today, we will be presenting compelling real world data and evidence from multiple clinical trials that focuses on easing the burden of patient participation. 

Topics: Patient Experience, DIA 2018, Patient Recruitment

The Patient Experience Company

By BBK Worldwide on Mon, Jun 25, 2018 | 3 min read

Over the past 35 years, BBK Worldwide has driven the development of patient recruitment and engagement through our products, services, experience, and thought leadership. With this in mind, we are pleased to announce our new marketplace position as The Patient Experience Company.

Topics: Patient Experience, DIA 2018

Clinical Trial Advertisers: Take Note of These Digital Trends

By BBK Worldwide on Tue, Jun 5, 2018 | 3 min read

The way people consume media is changing. With a projected 237.6 million estimated smartphone users by the end of 2018 in the United States alone (an increase of 13.3 million users from last year), the way people are accessing information is increasingly going mobile. Additionally, the Pew Research Center suggests that 64 percent of Americans between the ages 50 to 64 are using social media, preferring mediums like Facebook and YouTube. While the clinical trial industry is known to be slow in adopting newer technologies, the implications of these observed trends for patient recruitment speak for themselves. To get a closer look at the impact of digital media on clinical trial advertising, we spoke with our Director of Media and Research Sarah Mandracchia for her insights on some of the tactics and strategies that are shaping direct-to-consumer outreach in 2018.

Topics: Digital Platforms, clinical trials, clinical research, advertising

Agree or Disagree: Qualified Referrals Keep Sites Engaged

By BBK Worldwide on Wed, May 2, 2018 | 1 min read

 

While sites should be held accountable for processing the referrals that are generated from clinical trial advertising, it is very important that these referrals are qualified so that sites are not wasting their time. Therefore, generating highly qualified referrals is the number one contributing factor to site engagement.

Do you agree? Disagree? Watch the latest clip from our first episode of Pharma15 Live! and leave a comment below.

Topics: Pharma15

Agree or Disagree: Clinical Trial Sites Must Invest in Branding

By BBK Worldwide on Mon, Apr 30, 2018

There is a difference between “advertising” to generate referrals for clinical studies and “branding” for clinical trial sites. To remain relevant in a changing media landscape, sites must allocate part of their advertising budget to invest in branding. Do you agree? Disagree? Leave a comment below.

Topics: Pharma15

Agree or Disagree: Regulatory Bodies Need Social Media Training

By BBK Worldwide on Wed, Apr 25, 2018

If regulatory bodies are reviewing advertising and content for digital channels, like social media, should they receive education to understand how these channels work?

Check out the latest clip from our first Pharma15 Live! debate. Do you agree? Disagree? Leave a comment below.

Topics: clinical research, Social Media, Pharma15

Clinical Trial Advertising: Is It Just About Referrals?

By BBK Worldwide on Mon, Apr 23, 2018 | 1 min read

When it comes to direct-to-consumer advertising for clinical trials, is it just about generating referrals for sites? Or is the quality of the referral more important than quantity?

Watch this clip from our first Pharma15 Live! debate between industry experts. Do you agree or disagree? Comment below!

Topics: Pharma15

 
Subscribe To Our Blog